{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:44:10Z","timestamp":1784889850331,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum AB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011926","name":"EAHAD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016387","name":"Grifols SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.rpth.2024.102580","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T16:01:21Z","timestamp":1727971281000},"page":"102580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction model"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0380-8094","authenticated-orcid":false,"given":"Ilja","family":"Oomen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo M.","family":"Camelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bia M.R.A.","family":"Callado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luany E.M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia L.","family":"Calcaterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Carcao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Castaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen C.J.","family":"Eikenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathelijn","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian K.B.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn W.","family":"Heymans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank W.G.","family":"Leebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lillicrap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia S.","family":"Lorenzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elisa","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Matino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo N.D.","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex B.","family":"Mohseny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suely Meireles","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges-Etienne","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Rydz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia E.M.","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Voorberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Fijnvandraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha C.","family":"Gouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102580_bib1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1365-2516.2003.00780.x","article-title":"The epidemiology of inhibitors in haemophilia A: a systematic review","volume":"9","author":"Wight","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102580_bib2","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1182\/blood-2006-11-056291","article-title":"Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study","volume":"109","author":"Gouw","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102580_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the management of hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102580_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2141.2010.08263.x","article-title":"Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches","volume":"150","author":"Coppola","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102580_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000495454","article-title":"Inhibitors: a need for eradication?","volume":"141","author":"Santagostino","year":"2019","journal-title":"Acta Haematol"},{"key":"10.1016\/j.rpth.2024.102580_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/hae.14470","article-title":"Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors?","volume":"28","author":"Holstein","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102580_bib7","article-title":"Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis","volume":"7","author":"Oomen","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102580_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/hae.14431","article-title":"Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitors","volume":"28","author":"Di Minno","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102580_bib9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2011-08-369132","article-title":"The principal results of the International Immune Tolerance Study: a randomized dose comparison","volume":"119","author":"Hay","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102580_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5045\/br.2016.51.1.37","article-title":"Long-term course of anti-factor VIII antibody in patients with hemophilia A at a single center","volume":"51","author":"Yoo","year":"2016","journal-title":"Blood Res"},{"key":"10.1016\/j.rpth.2024.102580_bib11","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1111\/jth.15878","article-title":"Time between inhibitor detection and start of immune tolerance induction: association with outcome in the BrazIT study","volume":"20","author":"Camelo","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102580_bib12","doi-asserted-by":"crossref","first-page":"b375","DOI":"10.1136\/bmj.b375","article-title":"Prognosis and prognostic research: what, why, and how?","volume":"338","author":"Moons","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2024.102580_bib13","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood-2011-09-379453","article-title":"F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis","volume":"119","author":"Gouw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102580_bib14","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/j.1538-7836.2009.03615.x","article-title":"Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors","volume":"7","author":"Coppola","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102580_bib15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jtha.2022.12.017","article-title":"Race, ethnicity, F8 variants, and inhibitor risk: analysis of the \u201cMy Life Our Future\u201d hemophilia A database","volume":"21","author":"Ahmed","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102580_bib16","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1182\/blood.V110.11.1163.1163","article-title":"The role of race and ethnicity in the clinical outcomes of severe hemophilia a patients with inhibitors","volume":"110","author":"Kruse-Jarres","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102580_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/hae.12566","article-title":"Improved prediction of inhibitor development in previously untreated patients with severe haemophilia A","volume":"21","author":"Hashemi","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102580_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fepid.2022.975380","article-title":"Modeling non-linear relationships in epidemiological data: the application and interpretation of spline models","volume":"2","author":"Schuster","year":"2022","journal-title":"Front Epidemiol"},{"key":"10.1016\/j.rpth.2024.102580_bib19","doi-asserted-by":"crossref","first-page":"b604","DOI":"10.1136\/bmj.b604","article-title":"Prognosis and prognostic research: developing a prognostic model","volume":"338","author":"Royston","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2024.102580_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2024.102580_bib21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0","article-title":"Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets","volume":"19","author":"Steyerberg","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.rpth.2024.102580_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/10705510802339072","article-title":"What improves with increased missing data imputations?","volume":"15","author":"Bodner","year":"2008","journal-title":"Struct Equ Model"},{"key":"10.1016\/j.rpth.2024.102580_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.rpth.2024.102580_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12874-017-0404-7","article-title":"Methods for significance testing of categorical covariates in logistic regression models after multiple imputation: power and applicability analysis","volume":"17","author":"Eekhout","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.rpth.2024.102580_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12874-022-01693-8","article-title":"A\u00a0simple pooling method for variable selection in multiply imputed datasets outperformed complex methods","volume":"22","author":"Panken","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.rpth.2024.102580_bib26","first-page":"65","article-title":"Significance levels from repeated p-values with multiply-imputed data","volume":"1","author":"Li","year":"1991","journal-title":"Stat Sin"},{"key":"10.1016\/j.rpth.2024.102580_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2288-9-57","article-title":"Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines","volume":"9","author":"Marshall","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.rpth.2024.102580_bib28","first-page":"1065","article-title":"Large-sample significance levels from multiply imputed data using moment-based statitsics and an F reference distribution","volume":"86","author":"Li","year":"1991","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.rpth.2024.102580_bib29","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1111\/hae.14325","article-title":"Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A","volume":"27","author":"Hassan","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102580_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b605","article-title":"Prognosis and prognostic research: validating a prognostic model","volume":"338","author":"Altman","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2024.102580_bib31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.rpth.2024.102580_bib32","article-title":"Package 'psfmi': prediction model pooling, selection and performance evaluation across multiply imputed datasets","volume":"1.4.0","author":"Heymans","year":"2023","journal-title":"R\u00a0package version"},{"key":"10.1016\/j.rpth.2024.102580_bib33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/asheducation-2016.1.657","article-title":"Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches","volume":"2016","author":"Meeks","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2024.102580_bib34","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1538-7836.2009.03538.x","article-title":"The molecular mechanisms of immunomodulation and tolerance induction to factor VIII","volume":"7","author":"Waters","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102580_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159925","article-title":"Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs","volume":"132","author":"Becker-Gotot","year":"2022","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.rpth.2024.102580_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109115","article-title":"Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors","volume":"242","author":"Zuccherato","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102580_bib37","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3270","article-title":"Synthesis of FVIII in Hemophilia-A patients with the intron-22-inversion may modulate immunogenicity","volume":"19","author":"Pandey","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.rpth.2024.102580_bib38","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.4238\/2013.October.29.6","article-title":"Genetic composition of a Brazilian population: the footprint of the Gold Cycle","volume":"12","author":"Queiroz","year":"2013","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.rpth.2024.102580_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2516.2010.02429.x","article-title":"Immune tolerance induction in 31 children with haemophilia A: is ITI less successful in African Americans?","volume":"17","author":"Callaghan","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102580_bib40","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood-2014-09-599365","article-title":"Factor VIII gene variants and inhibitor risk in African American hemophilia A patients","volume":"126","author":"Gunasekera","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102580_bib41","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa075760","article-title":"Inhibitors of factor VIII in black patients with hemophilia","volume":"360","author":"Viel","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102580_bib42","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJMoa1516437","article-title":"A\u00a0randomized trial of factor VIII and neutralizing antibodies in hemophilia A","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102580_bib43","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.thromres.2010.10.006","article-title":"Immune tolerance induction in patients with hemophilia A","volume":"127","author":"Astermark","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102580_bib44","first-page":"87","article-title":"Immune tolerance induction: current status. Hematology Education; the education program for the annual congress of the European Hematology Association","volume":"7","author":"Hay","year":"2013","journal-title":"18th Congress of the European Hematology Association"},{"key":"10.1016\/j.rpth.2024.102580_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102436","article-title":"High levels of anti-factor VIII immunoglobulin G4 and immunoglobulin G total are associated with immune tolerance induction failure in people with congenital hemophilia A and high-responding inhibitors","volume":"8","author":"Chaves","year":"2024","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924002759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924002759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:22:58Z","timestamp":1732234978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924002759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2475037924002759"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102580","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction model","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102580"}}